Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10009167HBVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS20012030HPVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS20036049HPVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS20056806HPVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS44025067HTLV-1ENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TCGA Plot Options
Drug Information
GeneSCN5A
DrugBank IDDB06217
Drug NameVernakalant
Target IDBE0000197
UniProt IDQ14524
Regulation Typeblocker
PubMed IDs20592320
CitationsFinnin M: Vernakalant: A novel agent for the termination of atrial fibrillation. Am J Health Syst Pharm. 2010 Jul 15;67(14):1157-64. doi: 10.2146/ajhp080501.@@Dia E.Q., Rathbun R.A., Song J.C.: Vernakalant: A novel antiarrhythmic agent for the treatment of atrial fibrillation Formulary. 2007 August 1;42:475-483.
GroupsApproved; Investigational
Direct ClassificationTyrosols and derivatives
SMILESCOC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1
Pathways
PharmGKB
ChEMBLCHEMBL2111112